CSNK2A2 has been shown to be a significant biomarker of prognosis in hepatocellular carcinoma and might also be linked with the pathogenesis of abdominal aortic aneurysm [37, 38]. Here, CSNK2A2 is linked to hepatocellular carcinoma.